Mon, September 14, 2020
Fri, September 11, 2020
Thu, September 10, 2020

Anupam Rama Upgraded (VIR) to Hold and Decreased Target to $29 on, Sep 11th, 2020

Anupam Rama of JP Morgan, Upgraded "Vir Biotechnology, Inc." (VIR) to Hold and Decreased Target from $30 to $29 on, Sep 11th, 2020.

Anupam has made no other calls on VIR in the last 4 months.



There is 1 other peer that has a rating on VIR. Out of the 1 peers that are also analyzing VIR, 0 agree with Anupam's Rating of Hold.



This is the rating of the analyst that currently disagrees with Anupam


  • Alan Carr of "Needham" Initiated at Strong Buy and Held Target at $62 on, Thursday, August 20th, 2020